Read + Share
Amedeo Smart
Independent Medical Education
Liao JB, Jejurikar NS, Hitchcock-Bernhardt KM, Gwin WR, et al. Intraperitoneal immunotherapy with denileukin diftitox (ONTAK) in recurrent refractory ovarian cancer. Gynecol Oncol 2024;191:74-79.PMID: 39362046
Email
LinkedIn
Privacy Policy